NCT00268385 2026-03-19Vorinostat and Temozolomide in Treating Patients With Malignant GliomasNational Cancer Institute (NCI)Phase 1 Active not recruiting83 enrolled
NCT01266031 2018-07-31Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent GlioblastomaNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed96 enrolled 15 charts